Document Classification

Section Type: RESULTS

Text: After 12 weeks, the mean (95 % CI) percent changes from baseline in weekly hot flash frequency were as follows : placebo, -37. 4 % (-60. 9 to -14. 0) ; raloxifene, -14. 2 % (-37. 7 to 9. 3) ; paroxetine, -49. 8 % (-88. 6 to -11. 0) ; the mean (95 % CI) percent changes in hot flash severity were as follows : placebo, -39. 9 % (-69. 1 to -10. 8) ; raloxifene, -9. 6 % (-38. 8 to 19. 6) ; paroxetine, -36. 6 % (-84. 7 to 11. 5).